X4 Pharmaceuticals Prices $85.8 Million Public Offering of Common Stock and Class A Warrants – Business Wire

X4 Pharmaceuticals Prices $85.8 Million Public Offering of Common Stock and Class A Warrants Business Wire

X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment.